A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome

Nephrology Dialysis Transplantation

Volumn 26, Issue 2, 2011, Pages 739-741

  Maga, Tara K ^a,b   Meyer, Nicole C ^a   Belsha, Craig ^c   Nishimura, Carla J ^a   Zhang, Yuzhou ^a   Smith, Richard J H ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aHUS; complement; deletion; kidney transplantation

Indexed keywords

COMPLEMENT FACTOR H; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE; MEMBRANE COFACTOR PROTEIN;

ARTICLE; ARTIFICIAL VENTILATION; ATYPICAL HEMOLYTIC UREMIC SYNDROME; BLOOD TRANSFUSION; CASE REPORT; COMPLEMENT ALTERNATIVE PATHWAY; COPY NUMBER VARIATION; CREATININE BLOOD LEVEL; ERYTHROCYTE; EXON; FEVER; GENE CLUSTER; GENE DELETION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GRAND MAL SEIZURE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; INFANT; INFECTION; INTRON; IRRITABILITY; KIDNEY FAILURE; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LETHARGY; NONHUMAN; OLIGURIA; PALLOR; PRIORITY JOURNAL; RELAPSE; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SEPSIS; SERRATIA MARCESCENS; THERAPY EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANTIGENS, CD46; COMPLEMENT C3B INACTIVATOR PROTEINS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; MULTIGENE FAMILY; SEQUENCE DELETION;

EID: 79551489573     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq658     Document Type: Article

References (10)

1. Caprioli J, Noris M, Brioschi S et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108: 1267-1279
2. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676-1687
3. Maga TK, Nishimura CJ, Weaver AE et al. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 2010; 31: E1445-E1460
4. Venables JP, Strain L, Routledge D et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med 2006; 3: e431
5. Sanchez-Corral P, Gonzalez-Rubio C, Rodriguez de Cordoba S et al. Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Mol Immunol 2004; 41: 81-84
6. Dragon-Durey MA, Loirat C, Cloarec S et al. Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555-563
7. Schouten JP, McElgunn CJ,Waaijer R et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57
8. Fang CJ, Fremeaux-Bacchi V, Liszewski MK et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 2008; 111: 624-632
9. Loirat C, Fremeaux-Bacchi V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant 2008; 12: 619-629
10. Nurnberger J, Philipp T, Witzke O et al. Eculizumab for atypical hemolytic-uremic syndrome. N Engl J Med 2009; 360: 542-544